Tirzepatides dual agonist function targets both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor
Disclaimer: This newsletter is provided for educational and informational purposes only and does not constitute providing medical advice or professional services
Its your repair-and-resilience stack great after antibiotics, travel, or high-stress phases
Private Insurance Coverage in Canada Private insurance offers better coverage than provincial plans, but better doesnt mean good. Approximately 40-55% of private insurance plans in Canada provide some level of coverage for obesity medications based on claims data from 2024-2025
While the mechanism is plausible, the evidence does not yet exist to say what it does in people, at what dose, for what problem, or in which populations, especially in women
[2] [3] The tiredness experienced by some patients likely reflects both direct medication effects and indirect consequences of the medication's therapeutic actions on appetite, food intake, and metabolism